Press release
Trevigen Launches LDEV Free Basement Membrane Extract
Trevigen’s LDVE Free designation means that in addition to standard sterility, endotoxin and MAP testing, the BME is tested by PCR and is clear of 31 pathogens and viruses, including LDEV. Each lot is strictly qualified in biological performance assays. LDVE Free BME is offered in normal and reduced growth factor form, with and without phenol red, and is ideal for in vivo murine research work and other work requiring BME free from viruses, bacteria and mycoplasma.
The many applications for Cultrex Basement Membrane Extract, require different thicknesses and concentrations. Examples include use of diluted extract at 5 mg/ml for cell propagation and differentiation studies. Basement Membrane Extract is ideal for Tube Assay, Ring Assay, cell invasion studies, in vivo and in vitro angiogenesis assays, tumorgenicity and 3D Culture Assays.
This product is made and marketed under patent license from the United States Public Health Service. Ref. U.S. Patent 4,829,000 issued May 9, 1989 and U.S. Patent 5,158,874 issued October 27,1992, all entitled Reconstituted Membrane Complex with Biological Activity.
Press Contact:
Belinda De Leon
Trevigen, Inc.
1-800-873-8443
info@trevigen.com
www.trevigen.com
8405 Helgerman Ct.
Gaithersburg, MD 20877
Trevigen is a long standing provider of quality kits and reagents for researchers investigating programmed cell death, DNA damage and repair, cell differentiation and angiogenesis. Trevigen recently launched LDEV Free Basement Membrane Extract as part of its Cultrex® product line.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Trevigen Launches LDEV Free Basement Membrane Extract here
News-ID: 40802 • Views: …
More Releases from Trevigen, Inc.
HT PARP in vivo Pharmacodynamic Assay II
Trevigen announces a validated assay, with higher sensitivity and pre-coated antibody plates to measure the effectiveness of PARP inhibitors in cell and tissue lysates for anticancer drug screening.
Pharmacodynamic (PD) assays have recently been developed and employed early in the drug screening process to assess the ability of potential drug candidates to affect molecular targets. These assays have the advantages of performing molecular proof-of-concept investigations at an early stage such as…
Trevigen Releases CultreCoat® Cell Adhesion Assays
Trevigen announces the release of seven new coated well assay kits for cell adhesion studies.
A cell’s ability to adhere to extracellular matrix (ECM) proteins is a necessary precursor to cell invasion, and this process also modulates morphogenesis, wound healing, proliferation, differentiation, and survival. Researchers studying cancer cell behavior or developing cancer therapeutics study cell adhesion with various proteins, recognizing that manipulation of cell adhesion to the extracellular environment may…
Trevigen Announces the First Standardized Comet Assay Electrophoresis System
The comet assay is the only direct method for the detection of DNA damage in cells. It is used in cancer research, in genotoxicity studies on environmental mutagens, and for screening compounds for cancer therapeutics. Based on single cell gel electrophoresis in a controlled pH environment, the assay allows the integrity of stained nuclear DNA to be examined and measured.
Until now, a lack of standardization in electrophoresis equipment, control cells,…
Trevigen Announces a Highly Sensitive, Fluorescent, One Hour PARP Inhibition Ass …
Poly(ADP-ribose) polymerase, through ribosylation of nuclear proteins, converts DNA Damage into intracellular signals that actuate either DNA repair or cell death. The development of inhibitors to PARP is of ever increasing interest in the drug discovery community since they can be used as modulators of DNA repair mediated resistance to cytotoxic cancer therapeutics. Until now, commercially available PARP assay kits required multiple steps and were time consuming.
Trevigen overcomes these…
More Releases for Membrane
Increased Demand for Ophthalmology Amniotic Membrane to Boost the Amniotic Membr …
250 Pages Amniotic Membrane Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider
According to Fact MR's recent market research, sales of Amniotic Membrane to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.
Focus…
Amniotic Membrane Market continues to expand with Membrane Applications and Deve …
Amniotic membrane is an avascular layer of fetal membrane which can be extracted from placenta and stored in a sterile environment right after collection. It can be efficiently used in surgical procedures and in the treatment of ocular diseases or disorders such as ligneous conjunctivitis, corneal disease, etc. as well as for treating tissue damage. An amniotic membrane transplant (AMT) can be done using traditional suture and fibrin glue approach…
Ultrafiltration Membrane and Microfiltration Membrane Industry Outlook and Forec …
This report also researches and evaluates the impact of Covid-19 outbreak on the Ultrafiltration Membrane and Microfiltration Membrane industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Ultrafiltration Membrane and Microfiltration Membrane and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Global Info Research offers a latest published report on Ultrafiltration Membrane and Microfiltration Membrane Market Analysis and Forecast 2019-2025 delivering key insights…
Pharmaceutical Membrane Filtration Market – Notable Developments 2025 | Koch M …
Global Pharmaceutical Membrane Filtration Market: Snapshot
The global pharmaceutical membrane filtration market is envisaged to gain a strong impetus on the back of regulatory obligations on the part of cleanrooms in pharmaceutical production and improving growth of the generics market. Other factors that could fortify the growth of the global pharmaceutical membrane filtration market include technological developments in nanofibers and rising production of sizable biologics and molecules.
In terms of product, the…
Membrane Bioreactor Market 2017-2023 | Key Players GE Water and Process Technolo …
The membrane bioreactor is the technology for wastewater treatment industries, which is witnessing greater adoption in the global market. The market includes the study of various types of configurations, products, applications and geographic analysis. The membrane bioreactor technology is more advanced than conventionally activated sludge method of wastewater management. The technology is efficient due to lower operational and maintenance cost. The market is driven due to increased utilization of the…
Membrane Microfiltration Market 2018 - 2028 | By Membrane Type ( PES Membrane F …
Membrane Microfiltration Market: Value and Forecast
The global membrane microfiltration market is expected to expand at a CAGR of 7.8% in revenue terms over the forecast period 2018–2028. The global membrane microfiltration market is expected to be dominated by Western Europe with a 22.3% revenue share in 2018.
Membrane Microfiltration Market: Product Outlook
In water treatment systems, microfiltration membranes help in removing small particles and solids such as iron (rust), manganese (rust), clay, silt and…
